Tetrahydropalmatine has analgesic role in mouse model of bone cancer pain by inactivating the TNF-α/uPA/PAR2/TRPV1 pathway in dorsal root ganglia.

IF 6 2区 医学 Q1 ONCOLOGY
Guangda Zheng, Linghan Meng, Lu Shang, Juanxia Ren, Dongtao Li, Yanju Bao
{"title":"Tetrahydropalmatine has analgesic role in mouse model of bone cancer pain by inactivating the TNF-α/uPA/PAR2/TRPV1 pathway in dorsal root ganglia.","authors":"Guangda Zheng, Linghan Meng, Lu Shang, Juanxia Ren, Dongtao Li, Yanju Bao","doi":"10.1186/s12935-025-03972-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Treatment of bone cancer pain (BCP) remains a challenge. The current paper was to research the analgesic effect of Tetrahydropalmatine (THP) on BCP and the related mechanisms.</p><p><strong>Methods: </strong>Mouse model of BCP was constructed by injecting E0771 breast cancer cells into the tibia. Behavioral test was performed to research the effect of THP on pain nociception of BCP mice. Tibia and dorsal root ganglia (DRG) damage was evaluated by HE and Nissl staining. The construction of BCP cell models was conducted by co-culture DRG neurons with E0771 breast cancer cells. The effect of THP on the viability and apoptosis of BCP cell models was monitored by CCK-8 and Tunel assays. TNF-α/uPA/PAR2/TRPV1 pathway activity in DRG was detected by qRT-PCR and Western blot. Pomalidomide (PMA), exogenous TNF-α protein and Capsaicin were utilized to treat BCP mouse model and cell models to explore whether THP exerted analgesic effect via inactivating the TNF-α/uPA/PAR2/TRPV1 pathway.</p><p><strong>Results: </strong>THP attenuated pain nociception, relieved tibia destruction, and mitigated inflammation, neuronal death and neuronal excitotoxicity in DRG of BCP mice. It enhanced the viability, but suppressed the apoptosis of BCP cell models. The activated TNF-α/uPA/PAR2/TRPV1 pathway in BCP mouse model and cell models was abrogated by THP treatment. PMA and THP had additive effect, which combination attenuated pain nociception, tibia and DRG damage of BCP mice, and apoptosis of BCP cell models. The pain relief and the TNF-α/uPA/PAR2/TRPV1 pathway inactivation induced by THP in BCP mice was abolished by exogenous TNF-α protein or Capsaicin.</p><p><strong>Conclusion: </strong>THP exerted the analgesic role in BCP might be through inactivating the TNF-α/uPA/PAR2/TRPV1 pathway in DRG. It may be an effective drug for relieving BCP in patients.</p>","PeriodicalId":9385,"journal":{"name":"Cancer Cell International","volume":"25 1","pages":"328"},"PeriodicalIF":6.0000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495623/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cell International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12935-025-03972-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Treatment of bone cancer pain (BCP) remains a challenge. The current paper was to research the analgesic effect of Tetrahydropalmatine (THP) on BCP and the related mechanisms.

Methods: Mouse model of BCP was constructed by injecting E0771 breast cancer cells into the tibia. Behavioral test was performed to research the effect of THP on pain nociception of BCP mice. Tibia and dorsal root ganglia (DRG) damage was evaluated by HE and Nissl staining. The construction of BCP cell models was conducted by co-culture DRG neurons with E0771 breast cancer cells. The effect of THP on the viability and apoptosis of BCP cell models was monitored by CCK-8 and Tunel assays. TNF-α/uPA/PAR2/TRPV1 pathway activity in DRG was detected by qRT-PCR and Western blot. Pomalidomide (PMA), exogenous TNF-α protein and Capsaicin were utilized to treat BCP mouse model and cell models to explore whether THP exerted analgesic effect via inactivating the TNF-α/uPA/PAR2/TRPV1 pathway.

Results: THP attenuated pain nociception, relieved tibia destruction, and mitigated inflammation, neuronal death and neuronal excitotoxicity in DRG of BCP mice. It enhanced the viability, but suppressed the apoptosis of BCP cell models. The activated TNF-α/uPA/PAR2/TRPV1 pathway in BCP mouse model and cell models was abrogated by THP treatment. PMA and THP had additive effect, which combination attenuated pain nociception, tibia and DRG damage of BCP mice, and apoptosis of BCP cell models. The pain relief and the TNF-α/uPA/PAR2/TRPV1 pathway inactivation induced by THP in BCP mice was abolished by exogenous TNF-α protein or Capsaicin.

Conclusion: THP exerted the analgesic role in BCP might be through inactivating the TNF-α/uPA/PAR2/TRPV1 pathway in DRG. It may be an effective drug for relieving BCP in patients.

四氢巴马汀通过灭活背根神经节TNF-α/uPA/PAR2/TRPV1通路,在小鼠骨癌疼痛模型中具有镇痛作用。
背景:骨癌疼痛(BCP)的治疗仍然是一个挑战。本文旨在研究四氢巴马汀(THP)对BCP的镇痛作用及其机制。方法:采用E0771乳腺癌细胞注入胫骨建立小鼠BCP模型。采用行为学实验研究THP对BCP小鼠疼痛痛觉的影响。HE染色、尼氏染色观察胫骨及背根神经节(DRG)损伤情况。DRG神经元与E0771乳腺癌细胞共培养构建BCP细胞模型。采用CCK-8和Tunel法观察THP对BCP细胞模型细胞活力和凋亡的影响。采用qRT-PCR和Western blot检测DRG中TNF-α/uPA/PAR2/TRPV1通路活性。采用泊马度胺(Pomalidomide, PMA)、外源性TNF-α蛋白和辣椒素治疗BCP小鼠模型和细胞模型,探讨THP是否通过灭活TNF-α/uPA/PAR2/TRPV1通路发挥镇痛作用。结果:THP可减轻BCP小鼠DRG的疼痛痛觉,减轻胫骨损伤,减轻炎症、神经元死亡和神经元兴奋性毒性。提高BCP细胞模型的生存能力,抑制细胞凋亡。THP可消除BCP小鼠模型和细胞模型中活化的TNF-α/uPA/PAR2/TRPV1通路。PMA和THP具有叠加效应,可减轻BCP小鼠的疼痛痛觉、胫骨和DRG损伤以及BCP细胞模型的凋亡。外源性TNF-α蛋白或辣椒素可消除THP引起的BCP小鼠疼痛缓解和TNF-α/uPA/PAR2/TRPV1通路失活。结论:THP可能通过灭活DRG中TNF-α/uPA/PAR2/TRPV1通路发挥BCP镇痛作用。它可能是缓解BCP患者的有效药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.90
自引率
1.70%
发文量
360
审稿时长
1 months
期刊介绍: Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors. Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信